Literature DB >> 14576982

Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

P Nivoit1, N Wiernsperger, P Moulin, M Lagarde, C Renaudin.   

Abstract

AIMS/HYPOTHESIS: In vitro studies have suggested that glycation of LDL might be implicated in diabetic microangiopathy. We therefore investigated the in vivo effects of LDL glycated in vitro on the mouse skeletal muscle arteriolar tone. Since glycation naturally occurs during diabetes, we also tested the effects of LDL isolated from diabetic patients.
METHODS: In anaesthetized mice, the spinotrapezius muscle microcirculation was observed, in situ, using the orthogonal polarization spectral imaging technology. The diameter of terminal (<20 microm) and small arterioles (20-40 microm) was measured before and after a bolus intravenous injection of glycated LDL followed by a continuous perfusion (115 micro g/kg/min).
RESULTS: A slight decrease of terminal and small arterioles diameter (<10%) was observed with native LDL and LDL isolated from healthy subjects. In contrast, mildly glycated LDL induced a clear vasoconstriction of arterioles (>15%), which was further increased when highly glycated LDL was perfused (>22%). LDL isolated from diabetic patients mimicked the vasoconstriction obtained with in vitro mildly glycated LDL, which underwent similar glycation as those isolated from diabetic patients. CONCLUSION/
INTERPRETATION: Our results show in vivo that acute perfusion of both types of glycated LDL (artificially or naturally modified), cause major microvascular modification by enhancing arteriolar tone in skeletal muscle. These findings highlight a new role of glycated LDL at the level of microvessels. We suggest that glycation of LDL could contribute to the impaired vascular reactivity observed in diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576982     DOI: 10.1007/s00125-003-1225-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  A good practice guide to the administration of substances and removal of blood, including routes and volumes.

Authors:  K H Diehl; R Hull; D Morton; R Pfister; Y Rabemampianina; D Smith; J M Vidal; C van de Vorstenbosch
Journal:  J Appl Toxicol       Date:  2001 Jan-Feb       Impact factor: 3.446

2.  Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels.

Authors:  P Clarkson; D S Celermajer; A E Donald; M Sampson; K E Sorensen; M Adams; D K Yue; D J Betteridge; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

Review 3.  HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease.

Authors:  P O Kwiterovich
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

4.  Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans.

Authors:  S C Romerio; L Linder; J Flammer; W E Haefeli
Journal:  Peptides       Date:  2000-06       Impact factor: 3.750

5.  Glycated low density lipoproteins modify platelet properties: a compositional and functional study.

Authors:  G Ferretti; R A Rabini; T Bacchetti; A Vignini; E Salvolini; F Ravaglia; G Curatola; L Mazzanti
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.

Authors:  K Posch; S Simecek; T C Wascher; G Jürgens; S Baumgartner-Parzer; G M Kostner; W F Graier
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

Review 7.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

8.  In vivo effect of 8-epi-PGF2alpha on retinal circulation in diabetic and non-diabetic rats.

Authors:  E Michoud; M Lecomte; M Lagarde; N Wiernsperger
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1998-12       Impact factor: 4.006

9.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

10.  Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

Authors:  A Bowie; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Atherosclerosis       Date:  1993-08       Impact factor: 5.162

View more
  5 in total

1.  Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study.

Authors:  Simone H de Castro; Hugo C Castro-Faria-Neto; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2005-11-10

2.  Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice.

Authors:  Lin Zhu; Zhiqing He; Feng Wu; Ru Ding; Qixia Jiang; Jiayou Zhang; Min Fan; Xing Wang; Bengtsson Eva; Nilsson Jan; Chun Liang; Zonggui Wu
Journal:  Cardiovasc Diabetol       Date:  2014-11-13       Impact factor: 9.951

3.  Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications.

Authors:  Tejaskumar R Kalaria; Habibunnisha B Sirajwala; Mukesh G Gohel
Journal:  J Diabetes Metab Disord       Date:  2016-11-21

4.  AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells.

Authors:  Ao Cheng; Yuanyuan Dong; Fengxin Zhu; Youhua Liu; Fan Fan Hou; Jing Nie
Journal:  Int J Biol Sci       Date:  2013-01-03       Impact factor: 6.580

5.  Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.

Authors:  Anca V Sima; Gabriela M Botez; Camelia S Stancu; Adrian Manea; Monica Raicu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.